Thermo Fisher Holds 1.4% Post-Release Gain After Three Q2 Beats
06:00:30 ET
Reaction by asset (real prices)
| Asset | 2m before | At release | +1m | +10m | +1m % | +10m % | Vol vs normal |
|---|---|---|---|---|---|---|---|
| TMO | 530.00 | 539.46 | 539.46 | 547.01 | +1.79% | +3.21% | — |
At 6:00:30 a.m. ET on July 23, 2026, Thermo Fisher reported second-quarter revenue, adjusted operating income and adjusted earnings per share above the supplied expectations. TMO was $539.46 in the release minute, remained $539.46 one minute later and then rose to $547.01 by 10 minutes—a 1.40% post-release gain that held almost exactly through 15 minutes. The larger 3.209% span begins at $530 two minutes before the headline, so it includes price action already underway before the timestamp.
All three headline metrics cleared expectations
Thermo Fisher's July 23, 2026 results release reported revenue of $11.99 billion, adjusted operating income of $2.73 billion and adjusted EPS of $6.03. The expectations supplied with the headline were $11.7 billion, $2.59 billion and $5.72, respectively. The company also reported 10% revenue growth, 5% organic revenue growth and 13% adjusted EPS growth from the year-earlier quarter.
The first move began before the report timestamp
TMO was $530 two minutes before the headline and $539.46 in the release minute, a 1.785% advance. It then remained unchanged through the first minute after release before climbing to $547.01 at 10 minutes. That sequence matters: the stock responded positively after the results, but the full 3.209% move to the 10-minute price did not occur entirely after the headline.
The post-release gain held through 15 minutes
At 10 minutes, TMO was $547.01, up 1.40% from the $539.46 release-minute price. At 15 minutes, it was $547.00, up 1.398%. The one-cent difference shows virtually no fade between the two available checkpoints. The post-release path was therefore slower than the initial pre-timestamp jump but remained firmly positive once the stock reached the higher level.
A higher profit outlook broadened the earnings read
In reporting published later that morning, Reuters said on July 23, 2026 that Thermo Fisher raised its full-year adjusted EPS forecast to $24.93-$25.33 from $24.64-$25.12 as customer demand improved across its business segments. The company's results release separately said activity across its end markets continued to strengthen.
That later update broadened the read from three above-expectation quarterly metrics to improving demand and a higher profit outlook. It would still overstate the evidence to assign the stock's move to any single result or guidance item, particularly because part of the larger measured rise occurred before the earnings timestamp.
See it live, the moment it happens
MoveSurge surfaces market-moving headlines in seconds and attaches the real price reaction — so you read the move while it still matters.
Start Pro Start free View TMO in the live feed See pricing